← All stocks

Oruka Therapeutics, Inc.

ORKA Mostly scheduled
CIK 0000907654 #1126 in the set updated 22 Sep 2026
Bought (1 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (1 mo)
$10.42M
$104.63K on a plan · $9.89M straight out of an exercise
Sold at will
$420.84K
3 of 23 sales
Net
−$10.42M
−$420.84K against sales at will

By person

9 insiders · 23 transactions
141×

Lawrence Klein holds 141 times base salary in stock. $87.98M of shares against $624.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Lawrence Klein last reported holding, valued at $95.31, the price Common Stock was last bought or sold at on the open market here, on 21 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Klein Lawrence Otto
Chief Executive Officer
$7.12M (4) scheduled
−$7.12M
923,128
1.39%
$87.98M
+8.3%
Quinlan Paul T
General Counsel
$1.04M (5) scheduled
−$1.04M
29,995
0.0453%
$2.86M
Agarwal Arjun
Senior Vice President, Finance
$977.04K (6) scheduled
−$977.04K
14,219
0.0215%
$1.36M
+437.4%
Goncalves Joana
Chief Medical Officer
$734.14K (5) scheduled
−$734.14K
31,771
0.0480%
$3.03M
+1,659%
Sandler Laura Lee
Chief Operating Officer
$545.81K (3) scheduled
−$545.81K
235,478
0.3557%
$22.44M
+10.5%
Venrock Healthcare Capital Partners III, L.P. entity
10% owner
4,148,428
6.27%
$395.39M
+3.1%
Fairmount Funds Management LLC entity
Director
1,131,954
1.71%
$107.89M
+77.3%
Edwards Larry Todd
Chief Commercial Officer
100,000
0.1510%
$9.53M
Dambkowski Carl
Director
38,743
0.0585%
$3.69M

Nothing of that kind in this period.

What was left out

Form 4 filings counted 10
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 18
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 206,459
History held since 21 Sep 2016